Stock PHARMAID PHARMA AIDS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharma Aids Limited

Equities

PHARMAID

BD0462PHAID7

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 06:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
613.9 BDT -0.66% Intraday chart for Pharma Aids Limited -5.51% -22.36%
Apr. 24 Pharma Aids Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Jan. 30 Pharma Aids Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 2,148 1,896 1,273 1,241 2,543 2,467
Enterprise Value (EV) 1 2,164 1,901 1,264 1,222 2,519 2,463
P/E ratio 45.7 x 39.2 x 24.3 x 24.7 x 73.1 x -387 x
Yield 0.73% 0.82% 1.23% 1.26% 0.61% 0.13%
Capitalization / Revenue 9.14 x 7.61 x 4.72 x 4.43 x 7.87 x 8 x
EV / Revenue 9.21 x 7.63 x 4.69 x 4.36 x 7.8 x 7.99 x
EV / EBITDA 30.4 x 25.3 x 15.7 x 16.4 x 40.7 x 135 x
EV / FCF 426 x 102 x 58.5 x 70.2 x 125 x 250 x
FCF Yield 0.23% 0.98% 1.71% 1.42% 0.8% 0.4%
Price to Book 11.3 x 8.55 x 4.94 x 4.27 x 8.25 x 8.66 x
Nbr of stocks (in thousands) 3,120 3,120 3,120 3,120 3,120 3,120
Reference price 2 688.6 607.6 408.1 397.9 815.0 790.7
Announcement Date 11/25/18 12/12/19 12/16/21 12/16/21 12/13/22 11/9/23
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 235 249.1 269.6 280.3 323 308.5
EBITDA 1 71.13 75.09 80.41 74.61 61.84 18.29
EBIT 1 63.72 65.84 71.84 66.35 54.02 10.66
Operating Margin 27.11% 26.44% 26.65% 23.67% 16.72% 3.46%
Earnings before Tax (EBT) 1 62.68 64.41 69.97 65.35 53.54 10.3
Net income 1 47.01 48.31 52.47 50.26 34.76 -6.383
Net margin 20% 19.4% 19.47% 17.93% 10.76% -2.07%
EPS 2 15.07 15.48 16.82 16.11 11.14 -2.046
Free Cash Flow 1 5.079 18.59 21.6 17.41 20.13 9.862
FCF margin 2.16% 7.46% 8.01% 6.21% 6.23% 3.2%
FCF Conversion (EBITDA) 7.14% 24.75% 26.86% 23.33% 32.55% 53.93%
FCF Conversion (Net income) 10.8% 38.47% 41.16% 34.64% 57.9% -
Dividend per Share 2 5.000 5.000 5.000 5.000 5.000 1.000
Announcement Date 11/25/18 12/12/19 12/16/21 12/16/21 12/13/22 11/9/23
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 15.5 5.18 - - - -
Net Cash position 1 - - 9 19.7 23.9 3.64
Leverage (Debt/EBITDA) 0.2174 x 0.069 x - - - -
Free Cash Flow 1 5.08 18.6 21.6 17.4 20.1 9.86
ROE (net income / shareholders' equity) 27.3% 23.5% 21.9% 18.3% 11.6% -2.15%
ROA (Net income/ Total Assets) 16.5% 15.1% 14.9% 12.6% 9.35% 1.75%
Assets 1 284.4 320.5 351.6 398.7 372 -364.5
Book Value Per Share 2 60.80 71.10 82.50 93.30 98.80 91.30
Cash Flow per Share 2 1.830 3.140 4.510 6.400 7.980 4.850
Capex 1 27.5 1.8 5 10.3 4.7 2.21
Capex / Sales 11.69% 0.72% 1.85% 3.67% 1.45% 0.72%
Announcement Date 11/25/18 12/12/19 12/16/21 12/16/21 12/13/22 11/9/23
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PHARMA AIDS LIMITED Stock Pharma Aids Limited
-22.36% 16.29M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.96% 630B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.15% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.77% 328B
ABBVIE INC. Stock AbbVie Inc.
+8.79% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.02% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+1.27% 225B
NOVARTIS AG Stock Novartis AG
+11.95% 218B
AMGEN INC. Stock Amgen Inc.
+3.68% 160B
PFIZER, INC. Stock Pfizer, Inc.
-4.38% 156B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PHARMAID Stock
  4. Financials Pharma Aids Limited